Five Prime Therapeutics to Announce Third Quarter 2016 Financial Results and Host Conference Call on November 3
October 20 2016 - 4:05PM
Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage
biotechnology company focused on discovering and developing
innovative immuno-oncology protein therapeutics, will report its
third quarter 2016 financial results on Thursday, November 3, 2016,
after the U.S. financial markets close. Five Prime will host
a conference call and live audio webcast on Thursday, November 3,
2016, at 4:30 p.m. (ET)/1:30 p.m. (PT) to discuss the company’s
financial results and provide a general business update.
The live audio webcast may be accessed through the “Events &
Presentations” page in the “Investors” section of the company’s
website at www.fiveprime.com. Alternatively, participants may
dial (877) 878-2269 (domestic) or (253) 237-1188 (international)
and refer to conference ID 3243563.
The archived conference call will be available on Five Prime's
website beginning approximately two hours after the event and will
be archived and available for replay for at least 30 days after the
event.
About Five Prime
Five Prime Therapeutics, Inc. discovers and develops innovative
therapeutics to improve the lives of patients with serious
diseases. Five Prime's comprehensive discovery platform, which
encompasses virtually every medically relevant extracellular
protein, positions it to explore pathways in cancer, inflammation
and their intersection in immuno-oncology, an area with significant
therapeutic potential and a growing focus of the company's R&D
activities. Five Prime has entered into strategic collaborations
with leading global pharmaceutical companies and has promising
product candidates in clinical and preclinical development. For
more information, please visit www.fiveprime.com.
Company Contact:
Heather Rowe
Investor Relations
415-365-5737
Heather.rowe@fiveprime.com
Five Prime Therapeutics (NASDAQ:FPRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Five Prime Therapeutics (NASDAQ:FPRX)
Historical Stock Chart
From Sep 2023 to Sep 2024